INTRODUCTION
HA/TCP GRANULES is a substantiated alternative for autograft and allograft. It provides you with a biocompatible and osteoconductive material, without the need of harvesting or the use expensive donor material – with all related risks of rejection. HA/TCP GRANULES is composed of (40%) b-tricalcium phosphate and of (60%) hydroxyapetite. This composition is comparable to the mineral component in human bone tissue, making it the ideal environment for bone growth.
HANDLING AND PROCESSING EASE WITH HA/TCP GRANULES IN AN APPLICATOR
A Swiss-made applicator filled with HA/TCP GRANULES and fitted with a luer lock for aspirate injection of the blood or bone marrow. Fast, simple and immediately ready for use. HA/TCP GRANULES absorbs the aspirate and forms a firm emulsion enabling precise and controlled application.
CLINICAL EVIDENCE
More than 3,000 publications and over 500 clinical studies support the biocompatibility and clinical effectiveness of HA and b-TCP, as substitute for bone tissue. With this proven effectiveness, it is all about how we develop HA/TCP GRANULES what sets apart on the market. Including:
- An ultrahigh porosity of 83% for the fast growth of bone tissue
- A broad spectrum of sterile products (custom per unit) in a wide range of volumes.
- Natural bone density and 100% integration with the new bone tissue within twelve to fourteen weeks.
- An HA with a Ca/P ratio of 1.76, identical to human bone apatite.